Biocorp Production SA
PAR:ALCOR
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
FR |
Biocorp Production SA
PAR:ALCOR
|
154.4m EUR | 14.7 | ||
US |
Abbott Laboratories
NYSE:ABT
|
177.8B USD | 8.2 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
142.6B USD | 28.3 | ||
US |
Stryker Corp
NYSE:SYK
|
129.9B USD | 10.3 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
111.1B USD | 11.6 | ||
IE |
Medtronic PLC
NYSE:MDT
|
106.7B USD | 5.7 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.4B USD | 9.9 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.5B EUR | 8.6 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52.3B USD | 10.9 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
357.4B CNY | 14.5 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
47B USD | 19.4 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.